An updated study of the landmark X-ACT
trial, tracking data at 4.
feature provides an easy, convenient way to calibrate the Accel-a-Writer 3G to unequaled accuracy.
According to Heimann, recent generations of the company's X-ray security equipment can easily be retro-fitted with the X-ACT
sub-systems and components.
is a rapid cardiac SPECT/VCT imaging system that features a low-dose volume-computed tomography (VCT) attenuation correction system that significantly reduces artifacts in the images caused by overlying tissues increasing interpretive ease and accuracy.
In August this year, Roche filed an additional indication in Europe and the US for Xeloda to treat colon cancer patients after surgery, based on the successful results of the X-ACT
We're really thrilled to have the ability to reprogram the SALAGAR X-ACT
and use identical hardware in such diverse products, and do it all in a world-beating development timescale", he added.
We incorporated SALAGAR X-ACT
technology into the Symphony S210 to compensate for the natural spikes that arise from mid-bass cone resonances and other effects coming from transducer-cabinet integration," said Gary DiChiara, SALAGAR vice president and co-founder.
25 /PRNewswire/ -- Five-year follow-up overall survival data from the X-ACT
(Xeloda in Adjuvant Colon Cancer Trial) study show that oral chemotherapy Xeloda(R) (capecitabine) is as effective as the current standard treatment - intravenous bolus 5-FU/LV (5-fluorouracil/ leucovorin) - in the adjuvant treatment of Dukes' C colon cancer.
(Advanced Contents Tracking) - An automated recognition software program which identifies suspicious material screened in HI-SCAN series systems can be incorporated into the MSC 40.
Professor Jim Cassidy, Cancer Research UK Professor of Oncology and Chair of Medical Oncology, Beatson Oncology Centre, and University of Glasgow in Glasgow, Scotland, another of the lead investigators of the X-ACT
trial agreed, commenting, "According to some recent studies, most patients with cancer would prefer a convenient oral chemotherapy if they did not have to sacrifice efficacy.
THE ADJUVANT INDICATION WAS BASED ON DATA FROM THE X-ACT
He has published over 140 peer-reviewed articles in scientific and medical journals and has led high profile oncology clinical studies, including most recently, the X-ACT
study which contributed to the U.